RedChip Companies Inc. Logo

RedChip Emerging Growth Showcase on Jan. 22-23 Features Exclusive Interview With OPKO CEO Dr. Phil Frost

25 Emerging Growth Companies Presenting During Online Conference

| Source: RedChip Companies Inc.

ORLANDO, Fla., Jan. 17, 2014 (GLOBE NEWSWIRE) -- RedChip Companies, Inc. ("RedChip"), an international small-cap research, investor relations, and media company, today announced that the RedChip Emerging Growth Showcase on Wednesday and Thursday, January 22-23, 2014 will feature an exclusive interview with Dr. Phillip Frost, Chairman and CEO of OPKO Health, Inc. (OPK), a multinational biopharmaceutical and diagnostics company. Dr. Frost's interview will air at 9:30 a.m. Eastern time on both days of the conference at

During the RedChip Emerging Growth Showcase, 25 small-cap company executives will provide detailed overviews of their businesses through video presentations and live Q&A sessions. Thousands of investors are expected to participate. The online investor conference will air between 9:30 a.m. and 4 p.m. ET on both days at

Presenting companies range across a broad spectrum of industries and sectors, including oil & gas, technology, mining, healthcare, consumer goods, energy and more. Investors can pre-submit a question for a presenting company by visiting Presenting companies include:

-- ChromaDex Corp. (OTCQB:CDXC) (Jan. 23, 12:30 p.m. ET)

-- Green Innovations Ltd. (OTCQB:GNIN) (Jan. 23, 1:00 p.m. ET)

-- StarStream Entertainment (OTCQB:SSET) (Jan. 23, 2:30 p.m. ET)

-- GlyEco, Inc. (OTCQB:GLYE) (Jan. 23, 3:30 p.m. ET)

--, Inc. (OTCQB:USEL) (Jan. 22, 2:00 p.m. ET)

For a full list of presenting companies, visit No registration is required to participate in the conference. Start times are subject to change.

About Dr. Phillip Frost

Dr. Frost has successfully founded several pharmaceutical companies and overseen the development and commercialization of a multitude of pharmaceutical products. This combined with his experience as a physician and chairman and/or chief executive officer of large pharmaceutical companies has given him insight into virtually every facet of the pharmaceutical business and drug development and commercialization process.

Dr. Frost has been the CEO and Chairman of OPKO since March 2007. Dr. Frost was named the Chairman of the Board of Teva Pharmaceuticals in March 2010 and had previously been Vice Chairman since January 2006 when Teva acquired IVAX Corporation. Dr. Frost had served as Chairman and CEO of IVAX since 1987. He was Chairman of the Department of Dermatology at Mt. Sinai Medical Center of Greater Miami from 1972 to 1986. Dr. Frost was Chairman of Key Pharmaceuticals from 1972 until the acquisition of Key Pharmaceuticals by Schering Plough in 1986. Dr. Frost was named Chairman of Ladenburg Thalmann Financial Services Inc., in July 2006 and has been a director of Ladenburg Thalmann from 2001 until 2002 and again since 2004. Dr. Frost also serves as Chairman of PROLOR, a development stage biopharmaceutical company. He serves as a member of the Board of Trustees of the University of Miami and as a Trustee of each of the Miami Jewish Home for the Aged and the Mount Sinai Medical Center. Dr. Frost is also a director of Castle Brands, a developer and marketer of premium brand spirits. Dr. Frost previously served as a director for Continucare Corporation, Northrop Grumman Corp., and Ideation Acquisition Corp., as Governor and Co-Vice-Chairman of the American Stock Exchange and as a member of the Board of Trustees of the Scripps Research Institute until November 2012.

About RedChip Companies, Inc.

RedChip Companies, an Inc. 5000 company, is an international small-cap research, investor relations, and media company headquartered in Orlando, Florida; with affiliate offices in San Francisco, Pittsburgh, and Seoul. RedChip delivers concrete, measurable results for its clients through its extensive global network of small-cap institutional and retail investors. RedChip has developed the most comprehensive platform of products and services for small-cap companies, including: RedChip Research™, Traditional Investor Relations, Digital Investor Relations, Institutional and Retail Conferences, Virtual Conferences, "The RedChip Money Report: Small Stocks Big Money"™ television show, Shareholder Intelligence, Strategic Marketing, Crisis Management, Social Media and Blogging Services, and Webcasts. To learn more about RedChip's products and services, please visit:

"Discovering Tomorrow's Blue Chips Today"™

Jon Cunningham
RedChip Companies, Inc.
Tel: 1-800-RED-CHIP (733-2447), ext. 107